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Introduction
Cancer is one of the leading causes of death in the world (1). 
It is predicted that cancer will be the first and most 
important cause of death in 2030 (2). Colorectal cancer 
(CRC) is one of the most common types of cancers in the 
gastrointestinal tract (3). It is also the third most common 
cancer in men (746,000 cases, 10% of all cancers) and the 
second most common cancer in women (614,000 cases, 9.2% 
of all cancers) worldwide (4). According to recent studies 
in northern part of Iran, CRC is one of the most common 
cancers and its trend has been increasing in recent years (5). 
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Background: Colorectal cancer (CRC) is one of the most common types of gastrointestinal cancers. This 
study aimed to determine the demographic characteristics and their relationships with the results of the first 
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Methods: This cross-sectional study was conducted in 2016 on 924 eligible people over 50 years old. 
Initial screening was done by IFOBT and then colonoscopy was performed if the results were positive. The 
demographic characteristics of individuals including age, sex, place of residence, marital status, body mass 
index (BMI) and education level were investigated with the results of the colonoscopy and the test results.
Results: The mean age of participants was 59.38 years, and the participation of women (57.0%) and rural 
residents (54.2%) were higher in the screening program. According to the demographic variables, age was 
considered as a strong independent predictor variable, so that the prevalence of positive test results was more 
than 2 times higher in subjects older than 70 compared with subjects aged ≤60 (OR =2.05; 95% CI, 1.18–3.55, 
P=0.010). Also, the chance of positive test result in the age group ≤55 years old was 23%, with an increase 
of 64% in the age group above 75 years (P<0.001). Among the positive test subjects, 118 cases underwent 
colonoscopy. 
Conclusions: The prevalence of IFOBT positivity was increased with age. Therefore, given the aging 
population of the country, it is recommended to emphasize on the screening of older people in the general 
population.
Keywords: Colorectal cancer (CRC); screening; demographic characteristics; Iran
Submitted Jan 12, 2018. Accepted for publication Mar 01, 2018.
doi: 10.21037/jgo.2018.04.04
View this article at: http://dx.doi.org/10.21037/jgo.2018.04.04
465
459Journal of Gastrointestinal Oncology, Vol 9, No 3 June 2018
© Journal of Gastrointestinal Oncology. All rights reserved.   J Gastrointest Oncol 2018;9(3):458-465jgo.amegroups.com
CRC screening using screening tests significantly 
increases the survival rate of cancer. This is why CRC 
screening is strongly encouraged in different countries (6). 
Ideally, a screening method should be a simple and 
inexpensive test to apply easily for the entire population at 
risk. This criterion does not meet the colonoscopy because 
it is a golden standard approach. So those individuals with 
an IFOBT-positive test should do colonoscopy procedure. 
There is compelling evidence in terms of cost-effectiveness 
of CRC screening for population at risk. In addition, 
screening is recommended for asymptomatic individuals 
too, because there are symptoms of CRC or polyps that 
require colonoscopy diagnostic examination (7). Clinical 
trials and systematic reviews have shown that the 2-year 
screening program, by performing IFOBT and follow up 
with colonoscopy, can reduce the damages induced by the 
CRC up to 16% (8,9). Also, colonoscopy permits diagnosis 
and removal of polyps and cancer biopsy throughout the 
colon. Besides, both the sensitivity and the specificity of 
colonoscopy are appropriate for the diagnosis of polyps and 
cancer (7).
The screening program depends on the level of people’s 
knowledge, as well as their willingness and motivation to 
participate in the program. So, the program should be 
carefully planned (10,11) and regarded by researchers and 
managers of the health sector. For a successful screening 
program, the following multiple factors should occur: 
starting with the doctor’s advice, patient hospitalization, 
financial support, risk classification, screening test, timely 
diagnosis, timely treatment, and appropriate follow-up; 
if any of these steps fails or has low quality, the screening 
cannot succeed (12).
Demographic characteristics should be considered for 
a successful screening program. The various determinants 
of CRC screening prognosis are stated in different studies 
including age, gender, marital status, higher education, 
place of residence, race or ethnicity, family history of CRC, 
and doctor’s recommendation (13-16). Among them, age is 
an important factor in screening results. CRC risk increases 
by age and family history. CRC is rare before age 50, but 
then the cancer risk increases significantly (12). 
CRC is one of the most preventable cancers and there 
is no plan for its screening for the general population 
at medium risk in Iran. The current screening program 
is a colonoscopy for the first screening test and is only 
performed for high-risk individuals (first-degree relatives of 
the affected patients). The aim of this study was to examine 
the effect of demographic characteristics on all stages and its 
impact on the results of the first CRC screening program, 
including the results of IFOBT, as the most effective 
screening method, and the results of colonoscopy in people 
over 50 years old in northern part of Iran. This study also 
aimed to identify the variables of prognosis of the disease 
to help the community to prevent and control this kind of 
cancer.
Methods
This cross-sectional study was conducted from February 
to July 2016. Considering the high prevalence of positive 
FOBT based on the experts’ opinions and due to the 
potential drop of the participants during the study, the 
nature of screening and available resources, ultimately, the 
sample size included 924 individuals over 50 years old in 
Babol. At the beginning of the program, after coordination 
with the health department of Babol University of Medical 
Sciences, ten qualified health centers with full-time 
laboratories and full-time staff were selected as host centers. 
Regarding the population covered by each host center and 
considering the study as the first screening program for the 
medium risk individuals in the general population, sampling 
was performed using the convenience sampling method.
Exclusion and inclusion criteria were determined based 
on the study objectives. Inclusion criteria were individuals 
older than 50 years old, who were convinced to do the 
test in three stages and consented to cooperate till the 
end of the process. Exclusion criteria were the history of 
gastrointestinal surgery, diagnosed gastrointestinal diseases 
such as gastrointestinal ulcers, clear blood transfusions 
from the anus or the presence of visible blood in the feces, 
sinusitis, and blood in the sputum and secretions; For 
women, the days about to the menstrual period and up to 
3 days after the end of the menstruation, bleeding from the 
gums and oral mucosa during brushing, dental floss or any 
other agent (in this case, the test was postponed for several 
days and the person was advised to avoid tooth brushing 
and dental flossing in these days) and failure to provide two 
acceptable test samples.
All of the personnel and heads of the host centers 
had received two sessions of training course about the 
program at the center for Colorectal Cancer Counseling 
and Screening. Also, all health staff of the centers provided 
notification about the referral of the target group and free 
of charge services. After referring the individuals to the 
health centers, they were provided with the explanation 
of the study objectives by trained interviewers. Then 
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the questionnaires were completed through face-to-face 
interviews for those who signed the written informed 
consent. The study was approved by ethics committee 
of Shiraz University of Medical Sciences No. IR.SUMS.
REC.1396.S5807. The questionnaire was prepared by the 
researchers, consisting of demographic characteristics: age, 
sex, marital status, education, height and weight (BMI), 
place of residence (city or village) and results of the tests 
and the colonoscopy. At the end of the interview, the 
necessary education and counseling were also provided to 
the subjects about the importance of screening, healthy 
lifestyle and convincing them for cooperation during the 
screening program. Then the participants were introduced 
to the laboratory for the three tests. The immunochemical 
method, called Immunochemical Fecal Occult Blood Test 
(IFOBT), was also used in this study. 
Those participants for which the test result was positive 
(at least one positive result out of the three) were introduced 
to a state hospital (referring to the gastroenterologist at the 
colonoscopy unit of Shahid Beheshti and Ayatollah Rouhani 
Hospitals of Babol) for the colonoscopy to perform the 
necessary diagnostic and therapeutic procedures. 
Regarding the study objectives and type of variables, 
SPSS 22 software was used to analyze the data. Descriptive 
statistics (frequency, mean and standard deviation) were 
used to describe the exact study population. Independent 
Samples T-test and Binary Logistic Regression was used for 
analytical statistics and P<0.05 was considered statistically 
significant.
Results
A total number of 924 subjects were enrolled within 
6 months of screening. The mean age of the participants 
was 59.38±7.15 years. The participation of women (57.0%) 
and rural residents (54.2%) was higher. Participation 
rate decreased by increasing the age, and the highest 
participation rate was observed in the age group less than 
60 years. In terms of education level, the highest frequency 
(51.5%) belonged to elementary to high school group, and 
89.4% of subjects were married. In terms of BMI, the most 
of the cases (44.3%) were in the overweight group. The 
demographic characteristics of participants are shown in 
Table 1.
Among all the studied subjects, 897 cases (97.1%) provided 
at least two acceptable samples to the laboratory based 
on the preliminary guidance, in which 229 cases (25.5%) 
had at least one positive test result that were considered as 
positive IFOBT in this program. In terms of the differences 
in demographic characteristics according to the test 
results, the mean age was different (in the positive test: 
60.83±7.20 years versus the negative test: 58.88±7.08 years; 
P<0.001). Also, the results of regression analysis showed 
that age was considered as a strong independent predictor 
among demographic variables. The difference in the test 
results in age groups was different and significant in the 
one-way and multivariate regression analysis; so that, the 
prevalence of the positive test result was 64% higher in 
the age range of 61–70 years than the age group ≤60-year-
old (OR =1.64; 95% CI, 1.15–2.34, P=0.006). Also, 
the prevalence of the positive test result was more than 
2 times higher in subjects over 70 years old than ≤60 years 
(OR =2.05; 95% CI, 1.18–3.55, P=0.010). In terms of 
education, in the univariate analysis, the prevalence of 
positive test result was 50% less in university graduates than 
illiterates subjects; the difference was statistically significant 
(OR =0.50; 95% CI, 0.25–0.97, P=0.041). In the presence 
of other variables, although the prevalence of positive result 
was 46% less in university graduates than illiterate ones, 
but the difference was not significant (OR =0.54; 95% CI, 
0.26–1.13, P=0.106). The prevalence of IFOBT positive was 
Table 1 Demographic characteristics of the participants in CRC 
screening program of Babol County, Iran (n=924)
Variables Groups Frequency (%)
Place of residence Urban 423 (45.8)
Rural 501 (54.2)
Sex Male 397 (43.0)
Female 527 (57.0)
Age group (years) 50–59 567 (61.4)
60–69 280 (30.3)
≥70 77 (8.3)
Education Illiterate 373 (40.4)
Primary to high school 476 (51.5)
Academic 75 (8.1)
Marital status Married 826 (89.4)
Single 98 (10.6)
BMI <25 kg/m2 206 (22.3)
≥25 to <30 kg/m2 409 (44.3)
≥30 kg/m2 309 (33.4)
CRC, colorectal cancer.
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13% lower in rural residents than in urban residents, and 
it was 6% higher in women than in men and 20% higher 
in obese subjects than normal BMI people. None of these 
differences were statistically significant (Table 2).
The likelihood of a positive test result (IFOBT) based on 
age groups of 5 years. The results presented in Table 3 show 
that the chance of positive test result in the age group ≤55 
was 23% less, which was increased by 64% in the age group 
above 75. The results of the trend test also confirmed this 
increase by increasing age (P<0.001) (Table 3). In a further 
investigation in terms of the percentage of positive test 
results in different age groups based on gender (Figure 1), 
this trend was significant for both sexes, but the trend test 
was only statistically significant in women (P<0.001). 
Among 229 patients with positive IFOBT, 118 cases 
(64.1%) were referred to the hospital for colonoscopy. In 
examining the differences in the demographic characteristics 
of the subjects who had positive test results, there was no 
significant difference between the mean age of the subjects 
referring to colonoscopy (mean ± SD of colonoscopy 
cases: 60.50±7.08 years versus non-colonoscopy subjects, 
61.18±7.34 years); (P=0.477). Colonoscopy cases compared 
to non-colonoscopy subjects had a higher proportion 
in terms of male participants, urban residents, married 
subjects, and obese individuals. Although there are minor 
differences, none of them were statistically significant 
(P>0.05). The results presented in Table 4 show that the 
demographic characteristics in the two groups were similar 
and the results of screening in the colonoscopy group could 
be generalized to the non-colonoscopy group. In this study, 
three cases of CRC and 28 polyps were identified from 
colonoscopy group.
Discussion
This study is the first estimate of CRC screening on the 
demographic characteristics in the general population 
for people at moderate risk who aged over 50 years in 
northern part of Iran (Babol). The results of this study 
showed that the participation of women and rural residents 
in the screening program was higher and the participation 
rate was declined by increasing the age. Among the 
Table 2 Demographic characteristics by IFOBT in CRC screening program of Babol County, Iran (n=897)
Variables Groups
IFOBT, positive, 
N (%)
IFOBT, negative, 
N (%)
OR*(95% CI) P OR**(95% CI) P
Place of 
residence
Urban 111 (26.9) 302 (73.1) Reference group
Rural 118 (24.4) 366 (75.6) 0.87 (0.64–1.18) 0.393 0.85 (0.61–1.18) 0.346
Sex Male 95 (24.8) 288 (75.2) Reference group
Female 134 (26.1) 380 (73.9) 1.06 (0.78–1.44) 0.667 1.04 (0.74–1.46) 0.804
Age group 
(years)
≤60 118 (22.1) 417 (77.9) Reference group
61–70 83 (31.4) 181 (68.6) 1.62 (1.16–2.25) 0.004 1.64 (1.15–2.34) 0.006
≥71 28 (38.4) 45 (61.6) 2.19 (1.31–3.67) 0.003 2.05 (1.18–3.55) 0.010
Education Illiterate 105 (28.8) 259 (71.2) Reference group
Primary to 
high school
112 (24.2) 350 (75.8) 0.78 (0.57–1.07) 0.136 0.92 (0.64–1.31) 0.667
Academic 12 (16.9) 59 (83.1) 0.50 (0.25–0.97) 0.041 0.54 (0.26–1.13) 0.106
Marital status Married 201 (25.0) 603 (75) Reference group
Single 28 (30.1) 65 (69.9) 1.29 (0.80–2.07) 0.285 1.06 (0.63–1.80) 0.831
BMI ≤25 48 (24.7) 146 (75.3) Reference group
25.01–30 91 (23.6) 294 (76.4) 0.94 (0.63–1.40) 0.769 0.95 (0.62–1.44) 0.820
≥30.01 81 (28.3) 205 (71.7) 1.20 (0.79–1.82) 0.386 1.22 (0.78–1.90) 0.374
*, Crude odds ratio; **, fully adjusted odds ratio, adjusted for age, sex, place of residence, education, Marital status and BMI. OR: odds 
ratio. CRC, colorectal cancer.
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demographic variables in the results of the screening test, 
age was considered as a strong independent predictor for 
positive IFOBT. Also, there was no difference in terms of 
demographic characteristics between those who attended 
colonoscopy and those who not. 
Participation is a key indicator of the success for any 
program. After completing the questionnaires, 97.1% 
of subjects had at least two acceptable samples to the lab 
based on the initial guidelines. In patients with positive 
test results, about two-thirds of them were referred to the 
hospital for colonoscopy. In Iran, a cross-sectional study 
by Mirzaei et al. reported that on the evaluation of CRC 
screening program (screening for relatives of patients), the 
rate of primary participation and colonoscopy cases were 
53.3% and 54.8%, respectively. Their target group was 
the first-degree relatives who were at the higher risk (17). 
In a population-based cross-sectional study entitled CRC 
screening behaviors and related factors in the elderly 
population of China (over 50 years old) who were invited by 
phone calls, the participation rate was 66.6%, and the rate 
of attending the IFOBT and colonoscopy tests were 19% 
and 12%, respectively (18). In a CRC screening program 
in UK in the first stage, 56.7% of IFOBT and 82.7% of 
those who had positive test results were participated in the 
colonoscopy program (19). In the study by Mansouri et al 
in Iran, 76% of participants who had positive test result 
performed the colonoscopy (20). In a Canadian study, 
which was the first screening program in five provinces, 
colonoscopy participation was 80.2% (21). The difference 
in program coverage for different countries could be 
due to differences in the program’s target group, and 
the performing and sampling methods. Considering the 
invasive nature of the colonoscopy, the participation rate in 
the IFOBT screening program is significantly higher than 
colonoscopy (22), which is consistent with the results of 
present study.
Based on the results of present study, the participation 
of women and rural residents in the screening program 
was higher and the participation rate was declined by 
age. Previous studies indicated that male gender, older 
age, marital status, higher education, higher income, 
urban residence, and ethnicity were identif ied as 
Table 3 IFOBT positive odds by age groups in CRC screening program of Babol County, Iran
Age categories, years IFOBT, positive frequency IFOBT, negative frequency Odds 95% CI P. trend
≤55 60 254 0.23 0.17–0.31 <0.001
56–60 58 163 0.35 0.28–0.43
61–65 58 100 0.58 0.48–0.69
66–70 25 81 0.30 0.24–0.38
71–75 19 31 0.61 0.47–0.79
≥76 9 14 0.64 0.45–0.90
CRC, colorectal cancer.
Figure1 Trend of IFOBT positive percentage by gender and age groups in Screening Program of Babol County, Iran. P-trend for male 
=0.465 and female <0.001.
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screening attendance predictors among the demographic 
characteristics (15,16). In a cross-sectional study on the 
results of the first CRC screening program in Mexico, 74% 
of the participants were female (19), which is consistent 
with the results of present study. In the Mansouri study in 
Iran, fewer screening was associated with younger age, male 
gender, and social exclusion (20).
Participation rate in the first stage of screening was high 
in our study, which could be due to sampling method, and 
in the second stage –the colonoscopy- the participation rate 
was higher than the other study in Iran and to some extent 
was equal to studies of other countries, which can be due to 
ongoing follow-up during the program.
Except the study by Mirzaei in Iran, colonoscopy was 
performed in the second phase and for people who had 
positive IFOBT in all the studies of other countries. In 
some studies of other countries, kits were sent to individuals 
by mail. It should be noted that the most important 
barrier to reduce CRC mortality is the low participation in 
screening (23). The benefits of screening will only be high 
in the community once the participation is high. Moreover 
follow-up is an important matter during the program and 
colonoscopy (18). Barriers for CRC screening can be the 
lack of information, bad feeling about doing the test, and 
lack of proper justification by the doctor. So, increasing 
the community’s awareness and changing attitudes of the 
people, especially about colonoscopy, can increase the level 
of participation. All these demographic characteristics 
should be considered in planning a screening program.
Among demographic variables, age was considered as a 
strong independent predictor in IFOBT positive result. A 
study in the United States in which 10,702 individuals were 
participated in the study within a year, showed that 75.7% 
had at least one sample and 16.2% had at least one positive 
result and the rate of positivity was increased by age (24). 
In the Mansouri study, both men and older men were 
more likely to have positive tests; so that, the prevalence of 
positive test was 2.07 times higher in people ≥65 years old 
compared to those less than 55 years old (20). In general, 
positivity was increased by age, which is consistent with 
the results of this study. In our study, the prevalence of 
positive result in women was 6% higher, but in the study 
of Mansouri, 43% were lower in women (20), which is not 
consistent with the results of our study. Positive test result 
does not depend solely on the demographic characteristics 
and can be due to the different target groups, the program 
Table 4 Demographic characteristics by colonoscopy in CRC screening program of Babol County, Iran (n=229)
Variables Groups
Attended colonoscopy, N 
(%) 
Did not attend 
colonoscopy, N (%)
P
Place of residence Urban 63 (56.8) 48 (43.2) 0.125
Rural 55 (46.6) 63 (53.4)
Sex Male 51 (53.7) 44 (46.3) 0.583
Female 67 (50.0) 67 (50.0)
Age group (years) ≤60 60 (50.8) 58 (49.2) 0.965
61–70 43 (51.8) 40 (48.2)
≥71 15 (53.6) 13 (46.4)
Education Illiterate 50 (47.6) 55 (52.4) 0.348
Primary to high school 63 (56.3) 49 (43.8)
Academic 5 (41.7) 7 (58.3)
Marital status Married 105 (52.2) 96 (47.8) 0.564
Single 13 (46.4) 15 (53.6)
BMI ≤25 25 (52.1) 23 (47.9) 0.070
25.01–30 53 (58.2) 38 (41.8)
≥30.01 33 (40.7) 48 (59.3)
CRC, colorectal cancer.
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implementation, and many other factors that need to be 
investigated in other studies.
In the present study, for the subjects with positive 
test results, colonoscopy was performed. There was no 
statistically significant difference between colonoscopy 
and non- colonoscopy subjects in terms of demographic 
characteristics: males, urban residents and marital status. 
Men were tended to perform colonoscopy more than 
women. Perhaps it’s because women think that CRC is less 
important than other sexual cancers, such as breast cancer. 
Women may also have misunderstood that CRC is a male 
disease (25). 
In the present study, performing colonoscopy more in 
urban residents was also due to the quicker and easier access 
to hospital centers; it should be considered in screening 
program that rural residents should also have easy access 
to colonoscopy centers. Observing more married cases can 
also be justified by more support in the family.
The strength point of this study was that this was the 
first screening program in terms of investigating the 
demographic characteristics in asymptomatic individuals 
at moderate risk. This study also had limitations, including 
the small sample size and the fact that our sample cannot 
be representative of the population as a whole because of 
available sampling, participation of people over 50 years 
old, asymptomatic individuals and considering inclusion 
and exclusion criteria, or may be due to not considering all 
the potentially influencing factors on CRC. These features 
should be considered in interpreting the findings. Also, our 
analysis was based on one screening program. Longitudinal 
studies are needed to determine the complete screening 
behavior of people in terms of demographic characteristics. 
Due to the lack of the similar studies in the country, it 
is recommended to conduct similar and complementary 
researches in other areas with more populations to achieve 
better conclusion from the total results. Besides, health 
education and health promotion programs should also focus 
more on these identified factors to facilitate the screening 
of CRC in the population; based on the results of this study 
the screening of asymptomatic people over 50 in the general 
population should also be prioritized.
Acknowledgements
The assistance and cooperation of Health Deputy of Babol 
University of Medical Sciences and all the staff of health 
centers who helped us in data collection process are highly 
appreciated.
Funding: A substantial part of this study was supported by 
Research Council of Shiraz University of Medical Sciences 
for which we are thankful (Grant Number: 95-01-42-13948).
Footnote
Conflicts of Interest: The authors have no conflicts of interest 
to declare.
Ethical Statement: The study was approved by ethics 
committee of Shiraz University of Medical Sciences (No. 
IR.SUMS.REC.1396.S5807). Informed consent was 
obtained from all patients.  
References
1. Jemal A, Center MM, DeSantis C, et al. Global patterns 
of cancer incidence and mortality rates and trends. Cancer 
Epidemiol Biomarkers Prev 2010;19:1893-907.
2. National Cancer Registry Report 2003–2004. Tehran, 
Iran: Ministry of Health, Deputy for Health Directory, 
CDC Cancer Office 2004 (Persian). Available online: 
http://ircancer.ir
3. Center MM, Jemal A, Smith RA, et al. World wide variations 
in colorectal cancer. CA Cancer J Clin 2009;59:366-78.
4. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 
2012 v1.0, Cancer Incidence and Mortality Worldwide: 
IARC CancerBase No. 11 [Internet]. Lyon, France: 
International Agency for Research on Cancer; Available 
online: http://globocan.iarc.fr
5. Nikbakht HA, Aminisani N, Asghari Jafarabadi M, 
et al. Trends in the incidence of colorectal cancer and 
epidemiologic and clinical characteristics of survivors in Babol 
City in 2007-2012. J Babol Univ Med Sci 2015;16:7-14.
6. Minozzi S, Armaroli P, Segnan N. European guidelines 
for quality assurance in colorectal cancer screening and 
diagnosis. First Edition--Principles of evidence assessment 
and methods for reaching recommendations. Endoscopy 
2012;44 Suppl 3:Se9-14.
7. Winawer SJ. The multidisciplinary management of 
gastrointestinal cancer. Colorectal cancer screening. Best 
Pract Res Clin Gastroenterol 2007;21:1031-48.
8. Mandel JS, Church TR, Bond JH, et al. The effect of 
fecal occult-blood screening on the incidence of colorectal 
cancer. N Engl J Med 2000;343:1603-7.
9. Towler B, Irwig L, Glasziou P, et al. A systematic review 
of the effects of screening for colorectal cancer using the 
faecal occult blood test, hemoccult. BMJ 1998;317:559-65.
465Journal of Gastrointestinal Oncology, Vol 9, No 3 June 2018
© Journal of Gastrointestinal Oncology. All rights reserved.   J Gastrointest Oncol 2018;9(3):458-465jgo.amegroups.com
10. Lee CS, Ronan L, O'Morain C, et al. Screening for 
colorectal cancer: what fits best? Expert Rev Gastroenterol 
Hepatol 2012;6:301-12.
11. Stockbrugger R. Isolated colorectal cancer screening or 
integrated cancer prevention? A provocative suggestion! 
Dig Dis 2012;30:316-9.
12. Winawer S, Fletcher R, Rex D, et al. Colorectal cancer 
screening and surveillance: clinical guidelines and 
rationale-Update based on new evidence. Gastroenterology 
2003;124:544-60.
13. Shelton RC, Jandorf L, Ellison J, et al. The influence of 
sociocultural factors on colonoscopy and FOBT screening 
adherence among low-income Hispanics. J Health Care 
Poor Underserved 2011;22:925-44.
14. Fenton JJ, Tancredi DJ, Green P, et al. Persistent racial and 
ethnic disparities in up-to-date colorectal cancer testing in 
medicare enrollees. J Am Geriatr Soc 2009;57:412-8.
15. Mobley L, Kuo TM, Urato M, et al. Predictors of 
endoscopic colorectal cancer screening over time in 11 
states. Cancer Causes Control 2010;21:445-61.
16. Guessous I, Dash C, Lapin P, et al. Colorectal cancer 
screening barriers and facilitators in older persons. Prev 
Med 2010;50:3-10.
17. Mirzaei H, Panahi M, Etemad K, et al. Evaluation of Pilot 
Colorectal Cancer Screening Programs in Iran. Iranian 
Journal of Epidemiology 2016;12:21-8.
18. So WK, Choi KC, Chan DN, et al. Colorectal cancer 
screening behaviour and associated factors among Chinese 
aged 50 and above in Hong Kong - a population-based 
survey. Eur J Oncol Nurs 2012;16:413-8.
19. García-Osogobio S, Téllez-Ávila FI, Méndez N, et al. 
Results of the first program of colorectal cancer screening 
in Mexico. Endoscopia 2015;27:59-63.
20. Mansouri D, McMillan DC, Grant Y, et al. The impact 
of age, sex and socioeconomic deprivation on outcomes 
in a colorectal cancer screening programme. PLoS One 
2013;8:e66063.
21. Major D, Bryant H, Delaney M, et al. Colorectal cancer 
screening in Canada: results from the first round of 
screening for five provincial programs. Curr Oncol 
2013;20:252-7.
22. Quintero E, Castells A, Bujanda L, et al. Colonoscopy 
versus fecal immunochemical testing in colorectal-cancer 
screening. N Engl J Med 2012;366:697-706.
23. Sano Y, Byeon JS, Li XB, et al. Colorectal cancer screening 
of the general population in East Asia. Dig Endosc 
2016;28:243-9.
24. Allison JE, Tekawa IS, Ransom LJ, et al. A comparison of 
fecal occult-blood tests for colorectal-cancer screening. N 
Engl J Med 1996;334:155-9.
25. Meissner HI, Breen N, Klabunde CN, et al. Patterns of 
colorectal cancer screening uptake among men and women 
in the United States. Cancer Epidemiol Biomarkers Prev 
2006;15:389-94.
Cite this article as: Nikbakht HA, Ghaem H, Shokri-Shirvani J, 
Ghaffari-fam S, Alijanpour S. Demographic characteristics and 
the first program of colorectal cancer (CRC) screening in north 
of Iran (2016). J Gastrointest Oncol 2018;9(3):458-465. doi: 
10.21037/jgo.2018.04.04
